## BACKGROUND. Nonsmall cell lung carcinoma comprises approximately 75% of all lung carcinoma cases in the U.S. Newly evolving strategies have created considerable controversy regarding the optimal treatment for patients diagnosed with this disease. ## METHODS. A 17-item survey was designed to co
Patterns of angiogenesis in nonsmall-cell lung carcinoma
โ Scribed by Birgitte V. Offersen; Per Pfeiffer; Stephen Hamilton-Dutoit; Jens Overgaard
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 309 KB
- Volume
- 91
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
BACKGROUND. This is the first study on the quantitative assessment of thymidine phosphorylase (TP) activity in patients with nonsmall lung carcinoma. TP is identical to the platelet-derived endothelial cell growth factor with its angiogenic activity. Thus, it is believed that TP activity in tumor ti
The objective of this study was to examine and compare lifetime treatment patterns and hospitalization of incident nonsmall cell lung carcinoma (NSCLC) between pre-Medicare eligible (age ฯฝ 65 years) and supplemental Medigap (age ี 65 years) enrollees in a commercially insured cohort using insurance
## Background: Some patients with resected pn2 lung carcinoma were long term survivors. to determine appropriate therapeutic modalities for the selected patients, the clinicopathologic characteristics of these patients were examined using the actual number of survivors rather than the cumulative su